Seamus Fernandez
Analyst
Guggenheim Partners
Equibles does not estimate personal net worth.
About Seamus Fernandez
Seamus Fernandez is recorded as Analyst at Guggenheim Partners. Seamus Fernandez has spoken on 3 earnings calls and 1 other investor event across 2 companies, most recently for MBX Biosciences, Inc. on June 12, 2026. Those appearances were for MBX Biosciences, Inc. (MBX) and Mineralys Therapeutics, Inc. (MLYS). The companies whose calls Seamus Fernandez spoke on are classified in the Healthcare sector.
Seamus Fernandez on recent calls
“You know, Dr. Collins, interested to just get your thoughts on the comparison between, you know, the clinical comparison that one would make between Yorvipath and Canva Paratide's effectiveness here, you know, And perhaps, you know, improvements that you could see occurring between the phase two to phase three…”
“So I guess I'll address the – we're asking you to address the elephant in the room, which is you guys have been talking about potential partnering for quite some time.”
“So just to follow up on the commercial side of things, can you just help us understand, you know, what you believe the number of reps would be to, you know, launch the Larendra stat effectively versus AstraZeneca?”
“So, you know, a couple things to just clarify. We've got a lot of questions on the placebo response here. you know, and there's also a lot of questions on relative comparisons around that.”
Affiliation history
-
Guggenheim Partners
Analyst
Source not stated
Current